OM:BIOG BBiotechs
A Look at BioGaia (OM:BIOG B) Valuation Following Breakthrough Gut-Brain Serotonin Discovery
BioGaia (OM:BIOG B) just shared breakthrough research showing that two gut bacterial strains can generate serotonin, a neurotransmitter mostly made in the intestine. This discovery opens up new avenues for gut-brain health.
See our latest analysis for BioGaia.
While BioGaia’s serotonin breakthrough has put a spotlight back on its innovation, the stock tells a more nuanced story. After some short-term volatility and a recent earnings beat, the 1-year total shareholder return is nearly flat at...